Bg pattern

CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Clopidogrel Zentiva 75 mg Film-Coated Tablets

clopidogrel

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What Clopidogrel Zentiva is and what it is used for
  2. What you need to know before you take Clopidogrel Zentiva
  3. How to take Clopidogrel Zentiva
  4. Possible side effects
  5. Storage of Clopidogrel Zentiva
  6. Contents of the pack and other information

1. What Clopidogrel Zentiva is and what it is used for

Clopidogrel Zentiva contains clopidogrel and belongs to a group of medicines called antiplatelet agents. Platelets are very small cells in the blood that help it to clot. Antiplatelet agents prevent platelet clumping, reducing the risk of blood clots (a process called thrombosis).

Clopidogrel Zentiva is given to adults to prevent blood clots (thrombi) in the blood vessels (arteries) that supply the brain and heart, a process known as atherothrombosis, which can lead to atherothrombotic events (such as stroke, heart attack, or death).

You have been prescribed Clopidogrel Zentiva to help prevent blood clots and reduce the risk of these serious events because you have:

  • a condition that leads to hardening of the arteries (also known as atherosclerosis), and
  • previously had a heart attack, stroke, or have a condition known as peripheral arterial disease, or
  • experienced a severe form of chest pain known as "unstable angina" or "heart attack". For the treatment of this condition, your doctor may need to insert a stent in the obstructed or narrowed artery to restore proper blood flow. Your doctor may also have prescribed aspirin (a substance present in many medications used to relieve pain and reduce fever, as well as to prevent blood clots).
  • experienced symptoms of a stroke that disappeared within a short period (also known as a transient ischemic attack) or a mild ischemic stroke. Your doctor may also administer aspirin to you during the first 24 hours.
  • have an irregular heartbeat, a condition called "atrial fibrillation", and cannot take medicines known as "oral anticoagulants" (vitamin K antagonists) that prevent the formation of new clots and prevent the growth of existing clots.

You will have been told that "oral anticoagulants" are more effective than aspirin or the combined use of Clopidogrel Zentiva and aspirin for this condition. Your doctor will have prescribed Clopidogrel Zentiva plus aspirin if you cannot take "oral anticoagulants" and do not have a high risk of major bleeding.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Clopidogrel Zentiva

Do not take Clopidogrel Zentiva:

  • if you are allergic (hypersensitive) to clopidogrel or any of the other ingredients of this medicine (listed in section 6).
  • if you have an active bleeding, such as a stomach ulcer or bleeding in the brain.
  • if you have a severe liver disease.

If you think any of these apply to you, or if you are unsure, tell your doctor before taking Clopidogrel Zentiva.

Warnings and precautions

Before starting treatment with Clopidogrel Zentiva, tell your doctor if you:

  • have a risk of bleeding because:
  • you have a disease that involves a risk of internal bleeding (such as a stomach ulcer).
  • you have a blood disorder that makes you prone to internal bleeding (bleeding in tissues, organs, or joints of the body).
  • you have recently had a serious injury.
  • you have recently had surgery (including dental surgery).
  • you are going to have surgery (including dental surgery) in the next seven days.
  • have had a blood clot in an artery of the brain (ischemic stroke) in the last 7 days.
  • have liver or kidney disease.
  • have had an allergy or reaction to any medicine used to treat your condition.
  • have had a non-traumatic brain hemorrhage.

During treatment with Clopidogrel Zentiva:

  • tell your doctor if you are going to have surgery (including dental surgery).
  • tell your doctor immediately if you develop a disorder (also known as thrombotic thrombocytopenic purpura or TTP) that includes fever and bruising (bruises) under the skin that can appear as red spots, with or without unexplained extreme tiredness, confusion, yellow color of the skin or eyes (jaundice) (see section 4 "Possible side effects").
  • your doctor may ask you to have blood tests.

Children and adolescents

This medicine should not be given to children because it is not effective.

Taking Clopidogrel Zentiva with other medicines

tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines, including those obtained without a prescription.

Some medicines may affect the use of Clopidogrel Zentiva or vice versa.

You must tell your doctor if you are taking:

  • medicines that may increase the risk of bleeding, such as:
  • oral anticoagulants, medicines used to decrease blood clotting,
  • non-steroidal anti-inflammatory drugs, medicines used to treat pain and/or inflammation of muscles or joints,
  • heparin, or any other injectable medicine used to decrease blood clotting,
  • ticlopidine, another antiplatelet agent,
  • a serotonin reuptake inhibitor (such as fluoxetine or fluvoxamine and other drugs of the same type), medicines used to treat depression,
  • rifampicin (used for severe infections)
  • omeprazole or esomeprazole, medicines to treat stomach discomfort,
  • fluconazole or voriconazole, medicines to treat bacterial and fungal infections,
  • efavirenz, or other antiretroviral medicines (used to treat HIV infections),
  • carbamazepine, a medicine to treat some forms of epilepsy,
  • moclobemide, a medicine for depression,
  • repaglinide, a medicine for diabetes,
  • paclitaxel, a medicine for cancer,
  • opioids: if you are being treated with clopidogrel, you should tell your doctor before being prescribed any opioid (used to treat severe pain),
  • rosuvastatin (used to reduce cholesterol levels).

If you have had severe chest pain (unstable angina or heart attack), a transient ischemic attack, or a mild ischemic stroke, you may have been prescribed Clopidogrel Zentiva in combination with aspirin, a substance present in many medications used to relieve pain and reduce fever. A dose of aspirin given occasionally (not exceeding 1,000 mg in 24 hours) is generally not a problem, but prolonged use in other circumstances should be discussed with your doctor.

Taking Clopidogrel Zentiva with food and drinks

Clopidogrel Zentiva can be taken with or without food.

Pregnancy and breastfeeding

It is preferable not to take this medicine during pregnancy.

If you are pregnant or think you may be pregnant, you should tell your doctor or pharmacist before taking Clopidogrel Zentiva. If you become pregnant while taking Clopidogrel Zentiva, you should tell your doctor immediately, as it is not recommended to take clopidogrel during pregnancy.

You should not breastfeed while taking this medicine.

If you are breastfeeding or plan to breastfeed, you should tell your doctor before taking this medicine.

Ask your doctor or pharmacist for advice before taking any medicine.

Driving and using machines

Clopidogrel Zentiva is unlikely to affect your ability to drive or use machines.

Clopidogrel Zentiva contains lactose

If your doctor has told you that you have an intolerance to some sugars, you should consult them before taking this medicine.

Clopidogrel Zentiva contains hydrogenated castor oil

This may cause stomach upset and diarrhea.

3. How to take Clopidogrel Zentiva

Take this medicine exactly as your doctor or pharmacist has told you. If you are unsure, ask your doctor or pharmacist.

The recommended dose, even for patients with a condition known as "atrial fibrillation" (an irregular heartbeat), is one 75 mg tablet of Clopidogrel Zentiva per day, taken orally with or without food, and at the same time each day.

If you have had severe chest pain (unstable angina or heart attack), your doctor may prescribe you 300 mg or 600 mg of Clopidogrel Zentiva (1 or 2 tablets of 300 mg or 4 or 8 tablets of 75 mg) to be taken once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Zentiva per day, as described above.

If you have experienced symptoms of a stroke that disappeared within a short period (also known as a transient ischemic attack) or a mild ischemic stroke, your doctor may prescribe you 300 mg of Clopidogrel Zentiva (1 tablet of 300 mg or 4 tablets of 75 mg) once at the start of treatment. After that, the recommended dose is one 75 mg tablet of Clopidogrel Zentiva per day, as described above, with aspirin for 3 weeks.

After that, your doctor will prescribe either Clopidogrel Zentiva alone or aspirin alone.

You should take Clopidogrel Zentiva for as long as your doctor prescribes it.

If you take more Clopidogrel Zentiva than you should

Contact your doctor or go to the nearest hospital emergency department, as there is a higher risk of bleeding.

If you forget to take Clopidogrel Zentiva

If you forget to take a dose of Clopidogrel Zentiva, but remember before 12 hours have passed since the time you should have taken the medicine, take the tablet immediately and the next one at the usual time.

If you forget for more than 12 hours, simply take the next dose at the usual time. Do not take a double dose to make up for a forgotten tablet.

In the 7, 14, 28, and 84 tablet formats, you can check the last day you took a Clopidogrel Zentiva tablet by looking at the calendar printed on the blister pack.

If you stop taking Clopidogrel Zentiva

Do not stop taking your treatment unless your doctor tells you to.Contact your doctor or pharmacist before stopping treatment with this medicine.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Contact your doctor immediately if you experience:

  • fever, signs of infection, or extreme tiredness. These symptoms may be due to a rare decrease in some blood cells.
  • signs of liver problems, such as yellowing of the skin and/or eyes (jaundice), with or without bleeding that appears under the skin as red spots and/or confusion (see section 2 "Warnings and precautions").
  • swelling of the mouth or skin disorders such as rash and itching, blisters on the skin.

These may be signs of an allergic reaction.

The most common side effect reported with Clopidogrel Zentiva is bleeding. Bleeding may occur in the stomach or intestine, bruising, hematoma (abnormal bleeding or bruising under the skin), nosebleeds, blood in urine. A small number of cases of bleeding in the blood vessels of the eyes, intracranial bleeding, pulmonary or joint bleeding have also been reported.

If you experience prolonged bleeding while taking Clopidogrel Zentiva

If you cut or injure yourself, bleeding may take a little longer than usual to stop. This is related to the mechanism of action of the medicine, as it prevents the blood from forming clots. For minor cuts or injuries, such as cuts while shaving, this is usually not a problem. However, if you are concerned about your bleeding, consult your doctor immediately (see section 2 "Warnings and precautions").

Other side effects include:

Frequent side effects (may affect up to 1 in 10 people):

Diarrhea, abdominal pain, indigestion, or heartburn.

Uncommon side effects (may affect up to 1 in 100 people):

Headache, stomach ulcer, vomiting, nausea, constipation, excess gas in the stomach or intestine, rash, itching, dizziness, feeling of tingling and numbness.

Rare side effects (may affect up to 1 in 1,000 people):

Dizziness, breast enlargement in men.

Very rare side effects (may affect up to 1 in 10,000 people):

Jaundice, severe abdominal pain with or without back pain; fever, difficulty breathing, sometimes associated with cough; generalized allergic reactions (e.g., feeling of heat throughout the body with sudden general discomfort leading to fainting); swelling of the mouth; blisters on the skin, skin allergy; inflammation of the mouth mucosa (stomatitis); decrease in blood pressure; confusion; hallucinations; joint pain; muscle pain; changes in taste or loss of taste of food.

Side effects with unknown frequency (cannot be estimated from the available data):

Hypersensitivity reactions with chest or abdominal pain, persistent symptoms of low blood sugar.

Your doctor may also observe changes in the results of your blood or urine tests.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Clopidogrel Zentiva

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of the month.

See the storage conditions in the carton.

Store below 30°C when Clopidogrel Zentiva is presented in PVC/PVDC/aluminum blisters. When Clopidogrel Zentiva is presented in any aluminum blister, it does not require special storage conditions.

Do not use this medicine if you notice any visible signs of deterioration.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Package Contents and Additional Information

Clopidogrel Zentiva Composition

The active ingredient is clopidogrel. Each tablet contains 75 mg of clopidogrel (as hydrogen sulfate).

The other components are (see section 2 "Clopidogrel Zentiva contains lactose" and "Clopidogrel Zentiva contains hydrogenated castor oil"):

  • Tablet core: mannitol (E421), hydrogenated castor oil, microcrystalline cellulose, macrogol 6000, and low-substituted hydroxypropylcellulose.
  • Tablet coating: lactose monohydrate (milk sugar), hypromellose (E464),
  • triacetin (E1518), red iron oxide (E172), titanium dioxide (E171).
  • Varnish: carnauba wax.

Product Appearance and Package Contents

Clopidogrel Zentiva 75 mg film-coated tablets (tablets) are round, biconvex, pink, and engraved with the number "75" on one side and the number "1171" on the other. Clopidogrel Zentiva is available in cardboard boxes of:

  • 7, 14, 28, 30, 50, 84, 90, and 100 tablets in PVC/PVDC/Aluminum or Aluminum/Aluminum blisters,
  • 50x1 tablets in PVC/PVDC/Aluminum blisters or unit-dose perforated aluminum blisters.

Only some package sizes may be marketed.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Zentiva k.s.

U kabelovny 130

102 37 Prague 10

Czech Republic

Manufacturers:

Sanofi Winthrop Industrie

1, Rue de la Vierge, Ambarès & Lagrave, F-33565 Carbon Blanc cedex, France.

or

Delpharm Dijon

6, Boulevard de l’Europe, F - 21800 Quétigny, France

or

S.C. Zentiva S.A.

B-dul Theodor Pallady nr. 50, sector 3,

032266 Bucharest

Romania

For more information about this medicinal product, please contact the local representative of the Marketing Authorization Holder.

Belgium

Zentiva, k.s.

Tel: +32 280 86 420

[email protected]

Lithuania

Zentiva, k.s.

Tel: +370 52152025

[email protected]

Zentiva, k.s.

Tel: + 35924417136

[email protected]

Luxembourg

Zentiva, k.s.

Tel: +352 208 82330

[email protected]

Czech Republic

Zentiva, k.s.

Tel: +420 267 241 111

[email protected]

Hungary

Zentiva Pharma Kft.

Tel.: +36 1 299 1058

[email protected]

Denmark

Zentiva Denmark ApS

Tlf: +45 787 68 400

[email protected]

Malta

Zentiva, k.s.

Tel: +356 2778 0890

[email protected]

Germany

Zentiva Pharma GmbH

Tel: +49 (0) 800 53 53 010

[email protected]

Netherlands

Zentiva, k.s.

Tel: +31 202 253 638

[email protected]

Estonia

Zentiva, k.s.

Tel: +372 52 70308

[email protected]

Norway

Zentiva Denmark ApS

Tlf: +47 219 66 203

[email protected]

Greece

Zentiva, k.s.

Tel: +30 211 198 7510

[email protected]

Austria

Zentiva, k.s.

Tel: +43 720 778 877

[email protected]

Spain

Zentiva, k.s.

Tel: +34 931 815 250

[email protected]

Poland

Zentiva Polska Sp. z o.o.

Tel: + 48 22 375 92 00

[email protected]

France

Zentiva France

Tel: +33 (0) 800 089 219

[email protected]

Portugal

Zentiva Portugal, Lda

Tel: +351210601360

[email protected]

Croatia

Zentiva d.o.o.

Tel: +385 1 6641 830

[email protected]

Ireland

Zentiva, k.s.

Tel: +353 818 882 243

[email protected]

Romania

ZENTIVA S.A.

Tel: +4 021.304.7597

[email protected]

Slovenia

Zentiva, k.s.

Tel: +386 360 00 408

[email protected]

Iceland

Zentiva Denmark ApS

Phone: +354 539 0650

[email protected]

Slovakia

Zentiva, a.s.

Tel: +421 2 3918 3010

[email protected]

Italy

Zentiva Italia S.r.l.

Tel: +39-02-38598801

[email protected]

Finland

Zentiva Denmark ApS

Phone/Tel: +358 942 598 648

[email protected]

Cyprus

Zentiva, k.s.

Tel: +357 240 30 144

[email protected]

Sweden

Zentiva Denmark ApS

Tel: +46 840 838 822

[email protected]

Latvia

Zentiva, k.s.

Tel: +371 67893939

[email protected]

United Kingdom (Northern Ireland)

Zentiva, k.s.

Tel: +44 (0) 800 090 2408

[email protected]

Date of the Last Revision of this Leaflet: <{MM/AAAA}>

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu/

Online doctors for CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS

Discuss questions about CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS?
The active ingredient in CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS is clopidogrel. This information helps identify medicines with the same composition but different brand names.
Who manufactures CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS?
CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS is manufactured by Zentiva K.S.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to CLOPIDOGREL ZENTIVA 75 mg FILM-COATED TABLETS?
Other medicines with the same active substance (clopidogrel) include AGRELAN 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALMUS 75 mg FILM-COATED TABLETS, CLOPIDOGREL ALTER 75 mg FILM-COATED TABLETS. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media